情報源 > 更に詳しい情報[065]
参考文献

(1) Farwell AP, Braverman LE. Inflammatory thyroid disorders. Otolaryngol Clin North Am 1996; 4: 541-56.
(2) Kuhr T, Hala K, Dietrich H, Herold M, Wick G. Genetically determined target organ susceptibility in the pathogenesis of spontaneous autoimmune thyroiditis: aberrant expression of MHC-class II antigens and the possible role of virus. J Autoimmun 1994; 7: 13-25.
(3) Imaizumi M, Pritsker A, Unger P, Davies TF. Intrathyroidal fetal microchimerism in pregnancy and postpartum. Endocrinology 2002; 143: 247-53.
(4) Klintschar M, Schwaiger P, Mannweiler S, Regauer S, Kleiber M. Evidence of fetal microchimerism in Hashimoto's thyroiditis. J Clin Endocrinol Metab 2001; 86: 2494-8.
(5) Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham Survey. Clin Endocrinol (Oxf) 1977; 7: 481-93.
(6) Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA 1987; 258: 209-13.
(7) Hollowell GJ, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-99.
(8) Vanderpump MP, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55-68.
(9) Huber G, Staub JJ, Meier C, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 2002; 87: 3221-6.
(10) Chiovato L, Bassi P, Santini F, et al. Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 1993; 77: 1700-5.
(11) Tamaki H, Amino N, Kimura M, Hidaka Y, Takeoka K, Miyai K. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan. J Clin Endocrinol Metab 1990; 71: 1382-6.
(12) Giordano C, Stassi G, De Maria R, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960-3.
(13) Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 1999; 84: 4656-64.
(14) Tandon N, Zhang L, Weetman AP. HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1991; 34: 383-6. [Erratum, Clin Endocrinol (Oxf) 1994; 40: 702. ]
(15) Jenkins D, Penny MA, Fletcher JA, et al. HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1992; 37: 141-5.
(16) Vargas MT, Briones-Urbina R, Gladman D, Papsin FR, Walfish PG. Antithyroid microsomal antibodies and HLA-DR5 are associated with postpartum thyroid dysfunction: evidence supporting an autoimmune pathogenesis. J Clin Endocrinol Metab 1988; 67: 327-33.
(17) Waterman EA, Watson PF, Lazarus JH, Parkes AB, Darke C, Weetman AP. A study of the association between a polymorphism in the CTLA-4 gene and postpartum thyroiditis. Clin Endocrinol (Oxf) 1998; 49: 251-5.
(18) Lazarus JH, Hall R, Othman S, et al. The clinical spectrum of postpartum thyroid disease. QJM 1996; 89: 429-35.
(19) Fukata S, Kuma K, Sugawara M. Relationship between cigarette smoking and hypothyroidism in patients with Hashimoto's thyroiditis. J Endocrinol Invest 1996; 19: 607-12.
(20) Fung HY, Kologlu M, Collison K, et al. Postpartum dysfunction in mid Glamorgan. Br Med J (Clin Res Ed) 1988; 296: 241-4.
(21) Vitug AC, Goldman JM. Silent (painless) thyroiditis: evidence of a geographic variation in frequency. Arch Intern Med 1985; 145:473-5.
(22) Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998; 83: 765-9.
(23) Parkes AB, Black EG, Adams H, et al. Serum thyroglobulin: an early indicator of autoimmune post-partum thyroiditis. Clin Endocrinol (Oxf) 1994; 41: 9-14.
(24) Cooper DS. Subclinical hypothyroidism. N Engl J Med 2001; 345: 260-5.
(25) Weetman AP. Chronic autoimmune thyroiditis. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 721-32.
(26) Tsuboi K, Yuasa R, Tanaka Y, Ueshiba H, Takeda S, Ito K. Incidence of thyroid atrophy in patients with Hashimoto thyroiditis. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993: 69-72.
(27) Singer PA. Thyroiditis: acute, subacute, and chronic. Med Clin North Am 1991; 75: 61-77.
(28) Meier C, Staub JJ, Roth CB, et al. TSHcontrolled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001; 86: 4860-6.
(29) Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000; 132: 270-8.
(30) Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335: 99-107.
(31) Hayashi Y, Tamai H, Fukata S, et al. A long term clinical, immunological, and histological follow-up study of patients with goitrous chronic lymphocytic thyroiditis. J Clin Endocrinol Metab 1985; 61: 1172-8.
(32) Hegedus L, Hansen JM, Feldt-Rasmussen U, Hansen BM, Hoier-Madsen M. Influence of thyroxine treatment on thyroid size and anti-thyroid peroxidase antibodies in Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1991; 35: 235-8.
(33) Chiovato L, Marcocci C, Mariotti S, Mori A, Pinchera A. L-thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto's thyroiditis. J Endocrinol Invest 1986; 9: 299-305.
(34) Holm L-E, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312: 601-4.
(35) Matsubayashi S, Kawai K, Matsumoto Y, et al. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 1995; 80: 3421-4.
(36) Nikolai TF, Turney SL, Roberts RC. Postpartum lymphocytic thyroiditis: prevalence, clinical course, and long-term follow-up. Arch Intern Med 1987; 147: 221-4.
(37) Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 2001; 22: 605-30.
(38) Premawardhana LD, Parkes AB, Ammari F, et al. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 2000;85:71-5.
(39) Browne-Martin K, Emerson CH. Postpartum thyroid dysfunction. Clin Obstet Gynecol 1997; 40: 90-101.
(40) Lazarus JH, Ammari F, Oretti R, Parkes AB, Richards CJ, Harris B. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997; 47: 305-8.
(41) Roti E, Emerson CH. Postpartum thyroiditis. J Clin Endocrinol Metab 1992; 74: 3-5.
(42) Emerson CH, Farwell AP. Sporadic silent thyroiditis, postpartum thyroiditis, and subacute thyroiditis. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 578-89.
(43) Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am 1998; 27: 169-85.
(44) Nikolai TF, Coombs GJ, McKenzie AK. Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism and subacute thyroiditis: long-term follow-up. Arch Intern Med 1981; 141: 1455-8.
(45) Woolf PD. Transient painless thyroiditis with hyperthyroidism: a variant of lymphocytic thyroiditis? Endocr Rev 1980; 1: 411-20.
(46) Greene JN. Subacute thyroiditis. Am J Med 1971; 51: 97-108.
(47) Martino E, Buratti L, Bartalena L, et al. High prevalence of subacute thyroiditis during summer season in Italy. J Endocrinol Invest 1987; 10: 321-3.
(48) Volpe R, Row VV, Ezrin C. Circulating viral and thyroid antibodies in subacute thyroiditis. J Clin Endocrinol Metab 1967; 27: 1275-84.
(49) Kitchener MI, Chapman IM. Subacute thyroiditis: a review of 105 cases. Clin Nucl Med 1989; 14: 439-42.
(50) Iitaka M, Momotani N, Ishii J, Ito K. Incidence of subacute thyroiditis recurrences after a prolonged latency: 24-year survey. J Clin Endocrinol Metab 1996; 81: 466-9.
(51) Pearce EN, Martino E, Bogazzi F, et al. The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatorythyroid disease. Thyroid (inpress).
(52) Amino N, Yabu Y, Miki T, et al. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. J Clin Endocrinol Metab 1981; 53: 113-6.
(53) Hiromatsu Y, Ishibashi M, Miyake I, et al. Color Doppler ultrasonography in patients with subacute thyroiditis. Thyroid 1999; 9: 1189-93.
(54) Farwell AP. Infectious thyroiditis. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 1044-50.
(55) Golshan MM, McHenry CR, de Vente J, Kalajyian RC, Hsu RM, Tomashefski JF. Acute suppurative thyroiditis and necrosis of the thyroid gland: a rare endocrine manifestation of acquired immunodeficiency syndrome. Surgery 1997; 121: 593-6.
(56) Danahey DG, Kelly DR, Forrest LA. HIV-related Pneumocystis carinii thyroiditis: a unique case and literature review. Otolaryngol Head Neck Surg 1996; 114: 158-61.
(57) Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev 2001; 22: 240-54.
(58) Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997; 126: 63-73.
(59) Eaton SE, Euinton HA, Newman CM, Weetman AP, Bennet WM. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf)2002; 56: 33-8.
(60) Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994; 78: 423-7.
(61) Dickstein G, Shechner C, Adawi F, Kaplan J, Baron E, Ish-Shalom S. Lithium treatment in amiodarone-induced thyrotoxicosis. Am J Med 1997; 102: 454-8.
(62) Chopra IJ, Baber K. Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism. J Clin Endocrinol Metab 2001; 86: 4707-10.
(63) Bogazzi F, Bartalena L, Cosci C, et al. Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective randomized study. J Clin Endocrinol Metab 2003; 88: 1999-2002.
(64) Bogazzi F, Aghini-Lombardi A, Cosci C,et al. Lopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy. J Endocrinol Invest 2002; 25: 176-80.
(65) Bocchetta A, Mossa P, Velluzzi F, Mariotti S, Zompo MD, Loviselli A. Ten-year follow-up of thyroid function in lithium patients.J Clin Psychopharmacol 2001; 21: 594-8.
(66) Lazarus JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 1998; 8: 909-13.
(67) Barclay ML, Brownlie BE, Turner JG, Wells JE. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol (Oxf) 1994; 40: 759-64.
(68) Miller KK, Daniels GH. Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clin Endocrinol (Oxf) 2001; 55: 501-8.
(69) Mizukami Y, Michigishi T, Nonomura A, Nakamura S, Noguchi M, Takazakura E. Histological features of the thyroid gland in a patient with lithium-induced thyrotoxicosis. J Clin Pathol 1995; 48: 582-4.
(70) Marazuela M, Garcia-Buey L, Gonzalez- Fernandez B, et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-a therapy. Clin Endocrinol (Oxf) 1996; 44: 635-42.
(71) Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 1988; 318: 1557-63.
(72) Ronnblom LE, Alm GV, Oberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991; 115: 178-83.
(73) Wong V, Fu AX, George J, Cheung NW. Thyrotoxicosis induced by alpha-interferon
therapy in chronic viral hepatitis. Clin Endocrinol (Oxf) 2002; 56: 793-8.
(74) De Lange WE, Freling NJ, Molenaar WM, Doorenbos H. Invasive fibrous thyroiditis
(Riedel's struma): a manifestation of multifocal fibrosclerosis? A case report with review
of the literature. Q J Med 1989; 72: 709-17.
(75) Few J, Thompson NW, Angelos P, Simeone D, Giordano T, Reeve T. Riedel's thyroiditis: treatment with tamoxifen. Surgery 1996; 120: 993-8.
(76) Vaidya B, Harris PE, Barrett P, Kendall-Taylor P. Corticosteroid therapy in Riedel's
thyroiditis. Postgrad Med J 1997; 73: 817-9.

もどる